Prospect-MD Tablet
By Prospect
Rx
10 Tablet DT in a Strip

Composition
Ondansetron(4mg)

Manufacturer - Skymax Laboratories Pvt Ltd
A-510, Landmark Empires, Puna Kumbhariya Road, Magob, Surat-395 010, Gujarat(India).

Expires on or after
February, 2027

liver
Limited information is present regarding the use of Prospect-MD Tablet in individuals with liver conditions. It is crucial to seek guidance from your healthcare provider before considering this medication.

kidney
Prospect-MD Tablet is considered safe for patients with kidney disease. No dose adjustment is needed. Inform your doctor about any underlying kidney issues. Limited information is available for long-term use.

alcohol
When taking Prospect-MD Tablet, it is safe to consume alcohol as there are no harmful side effects known.

driving
Prospect-MD Tablet typically does not impact your driving ability.

pregnancy
Prospect-MD Tablet is generally safe to use during pregnancy based on animal studies with limited human data.

breastfeeding
Prospect-MD Tablet is considered safe for breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Carbazole Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Serotonin antagonists (5-HT3 antagonists) |
₹52
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024